CSE:AGN - Post Discussion
Post by
StockHawk1 on Jan 23, 2023 4:56pm
Article highlights AGN's DMT-Stroke Research
Algernon Pharmaceuticals (AGN.c AGNPF) looks like it is bouncing back, closing in the green today.
The Green Market Report recently featured the pharma tech company, highlighting its ongoing research on DMT.
Scientists at AGN believe that DMT's neurogenerative properties could make the drug a possible treatment for stroke survivors.
With the global stroke treatment market expected to reach $15B by 2027, this venture presents a large opportunity for AGN.
https://www.greenmarketreport.com/algernon-pharmaceuticals-looks-to-advance-dmt-stroke-research/
Be the first to comment on this post